p increased by 1.7%-points to Novo Nordisk ® Diabetes value market leadership expansion driven by the GLP-1 franchise Diabetes care sales grew by 24% (CER) with global value market share increase driven by GLP-1 market share gains in both IO and NAO. Global diabetes care market volume growth was ~4% • GLP-1 value market share has decreased by 0.7%-points in the last 12 months • Estimated global GLP-1 share of total diabetes prescriptions is ~5%
Download PDF file